The Latest Breaking News from European Commission

British nationals living in country are unable to access healthcare, change jobs or travel in and out

The European Commission said that Tehran and Washington should make "one last effort" to salvage a 2015 nuclear deal in talks that resumed in Vienna on Thursday, saying that political decisions are needed to overcome their impasse.

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

The European Union's privacy watchdogs on Friday criticised proposed rules to combat online child sexual abuse, saying their potential impact on individuals' privacy and personal data posed risks for fundamental rights and could harm the children they aim to protect.

The European Union found evidence that smartphones used by some of its staff were compromised by an Israeli company's spy software, the bloc's top justice official said in a letter seen by Reuters.

The Kremlin warns of retaliatory measures against Western media after the ruling by Luxembourg-based General Court.

Ukraine may have many years to wait before joining the European Union, but the war-battered country was granted a place alongside members of the bloc this week at "Mini-Europe", an open-air theme park of famous European landmarks.

Cameroon has emerged as one of several go-to countries for the widely criticized “flags of convenience” system, under which companies can -- for a fee -- register their ships in a foreign country even though there is no link between the vessel and the nation whose flag it flies

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…